Timothy Skalland, PhD
Staff Scientist, Biostatistics, Bioinformatics & Epidemiology
Vaccine and Infectious Disease Division, Fred Hutch
Research interests include the design and analysis of group-sequential and complex clinical trials, specifically as pertaining to HIV prevention trials.
Education
Oregon State University, 2015, PhD (Statistics)
Oregon State University, 2012, MS (Statistics)
William Jewell College, 2007, BA (Mathematics and Physics)
Research Interests
Design and analysis of group-sequential and complex clinical trials
Current Studies
Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART): A cluster-randomized trial of the impact of a combination prevention package on population-level HIV incidence in Zambia and South Africa (HPTN 071)
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (LA CAB) for the Prevention of HIV among Adolescents (HPTN 086)
Current Studies
Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART): A cluster-randomized trial of the impact of a combination prevention package on population-level HIV incidence in Zambia and South Africa (HPTN 071)
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (LA CAB) for the Prevention of HIV among Adolescents (HPTN 086)